Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening
- 1 February 2005
- Vol. 332 (1), 20-27
- https://doi.org/10.1016/j.virol.2004.10.048
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeysThe Lancet, 2003
- MannosylGlycodendritic Structure Inhibits DC-SIGN-Mediated Ebola VirusInfection in cis and in transAntimicrobial Agents and Chemotherapy, 2003
- Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virusAntiviral Research, 2003
- Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approachesVirus Research, 2003
- 3-Deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected miceAntiviral Research, 2002
- Monocyte-Derived Human Macrophages and Peripheral Blood Mononuclear Cells Infected with Ebola Virus Secrete MIP-1α and TNF-α and Inhibit Poly-IC-Induced IFN-α in VitroVirology, 2001
- Ebola Virus Defective Interfering Particles and Persistent InfectionVirology, 1999
- Antiviral Drug Therapy of Filovirus Infections: S‐Adenosylhomocysteine Hydrolase Inhibitors Inhibit Ebola Virus In Vitro and in a Lethal Mouse ModelThe Journal of Infectious Diseases, 1999
- A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic FeverThe Journal of Infectious Diseases, 1999
- Pathogenesis of Experimental Ebola Virus Infection in Guinea PigsThe Journal of Infectious Diseases, 1999